✦ LIBER ✦

Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia

✍ Scribed by Christie Ballantyne; Gilbert Gleim; Nancy Liu; Christine McCrary Sisk; Amy O. Johnson-Levonas; Yale Mitchel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of extended-release niacin/laropi

✍ James McKenney; Harold Bays; Michael Koren; Christie M. Ballantyne; John F. Paol 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 404 KB

SAFETY PROFILE OF EXTENDED-RELEASE NIACI

✍ McKenney, J.; Bays, H.; Koren, M.; Ballantyne, C.; Maccubbin, D.; Mitchel, Y.; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 218 KB

LIPID-ALTERING EFFICACY AND SAFETY PROFI

✍ Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Effect of niacin and atorvastatin on lip

✍ James M McKenney; Lisa S McCormick; Ernst J Schaefer; Donald M Black; Michael L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 224 KB

EFFICACY AND SAFETY OF EZETIMIBE/SIMVAST

✍ FAZIO, S; BROWN, B; GUYTON, J; POLIS, A; TOMASSINI, J; TERSHAKOVEC, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Long-term Effect of Combination Ezetimib

✍ Joanne E. Tomassini; Sergio Fazio; John Guyton; Andrew Tershakovec 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 78 KB